Container Closure Integrity (CCI) testing confirms the container closure system capability to provide required protection to the drug product and to demonstrate the maintenance of product sterility through commercial shelf-life stability.

Xepics has chosen to offer deterministic and non-destructive leak test method technologies in order to meet the parenteral packaging needs of our clients and the current regulatory requirements.

A deterministic method operates based on predictable physic/chemical phenomena and is therefore ideal for conclusive integrity evaluation; a non-destructive methods enables 100% testing, both online and offline, allowing for comprehensive analysis of defects and their root causes.